{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T19:31:17Z","timestamp":1777923077398,"version":"3.51.4"},"reference-count":38,"publisher":"SAGE Publications","issue":"9","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Microbial Drug Resistance"],"published-print":{"date-parts":[[2021,9]]},"abstract":"<jats:title>Microbial Drug Resistance<\/jats:title>\n                  <jats:p>\n                    officially retracts the paper entitled, \u201cDoes Fluoroquinolones and Third-Generation Cephalosporins Restriction Reverse Extended-Spectrum \u03b2-Lactamases\n                    <jats:italic toggle=\"yes\">Klebsiella pneumoniae<\/jats:italic>\n                    Resistance Rates?\u201d by Mirjana Stani\u0107 Beni\u0107, Dora Pal\u010devski, Romina Milani\u010d, Nata\u0161a Sko\u010dibu\u0161i\u0107, Maja Abram, and Vera Vlahovi\u0107-Pal\u010devski (Microb Drug Resist 27:1159\u20131166, 2021; DOI:10.1089\/mdr.2020.0301), at the authors' request.\n                  <\/jats:p>\n                  <jats:p>\n                    The Editor-in-Chief of the journal received correspondence from the corresponding author, Dr. Mirjana Stani\u0107 Beni\u0107, requesting a retraction of the published article due to \u201c\n                    <jats:italic toggle=\"yes\">shortcomings in statistical methodology. After the manuscript was published we, the authors, have received benevolent criticism from the readers who are senior and experienced experts, about the methodology that could have been more accurately handled (e.g. \u2018Considering the small number of data points\/months, there would have been better methods to analyze the effect of interventions, but multivariate time series analysis could not and should not have been used.\u2019) We appreciate the constructive criticism we have received and would like to correct the methodological mistake and improve the manuscript.<\/jats:italic>\n                    [sic]\u201d\n                  <\/jats:p>\n                  <jats:p>\n                    Dr. Stani\u0107 Beni\u0107 indicated in her message to the Editor-in-Chief that she and her team would resubmit a new manuscript \u201c\n                    <jats:italic toggle=\"yes\">with the same data but with revised analysis by using an adequate methodology. As our intervention was partly successful, we would still like to share our experience.<\/jats:italic>\n                    \u201d\n                  <\/jats:p>\n                  <jats:p>If such a submission is received by the journal, it will undergo full and proper peer review as per the journal's standard procedures.<\/jats:p>\n                  <jats:p>\n                    The Editor and Publisher of\n                    <jats:italic toggle=\"yes\">Microbial Drug Resistance<\/jats:italic>\n                    are committed to preserving the integrity of the scientific literature and the community it serves.\n                  <\/jats:p>","DOI":"10.1089\/mdr.2020.0301","type":"journal-article","created":{"date-parts":[[2021,3,19]],"date-time":"2021-03-19T15:39:42Z","timestamp":1616168382000},"page":"1159-1166","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":1,"title":["<b>\n                      <i>Retracted:<\/i>\n                    <\/b>\n                    Does Fluoroquinolones and Third-Generation Cephalosporins Restriction Reverse Extended-Spectrum \u03b2-Lactamases\n                    <i>Klebsiella pneumoniae<\/i>\n                    Resistance Rates?"],"prefix":"10.1177","volume":"27","author":[{"given":"Mirjana","family":"Stani\u0107 Beni\u0107","sequence":"first","affiliation":[{"name":"Department of Clinical Pharmacology, and Clinical Hospital Center Rijeka, Rijeka, Croatia."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dora","family":"Pal\u010devski","sequence":"additional","affiliation":[{"name":"Department of Emergency, Clinical Hospital Center Rijeka, Rijeka, Croatia."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Romina","family":"Milani\u010d","sequence":"additional","affiliation":[{"name":"Department of Medical Area, University of Udine, Udine, Italy."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nata\u0161a","family":"Sko\u010dibu\u0161i\u0107","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacology, and Clinical Hospital Center Rijeka, Rijeka, Croatia."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maja","family":"Abram","sequence":"additional","affiliation":[{"name":"Department of Clinical Microbiology, Clinical Hospital Center Rijeka, Croatia."},{"name":"Department of Microbiology and Parasitology, Faculty of Medicine, University of Rijeka, Rijeka, Croatia."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vera","family":"Vlahovi\u0107-Pal\u010devski","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacology, and Clinical Hospital Center Rijeka, Rijeka, Croatia."},{"name":"Department of Pharmacology, Faculty of Medicine, University of Rijeka, Rijeka, Croatia."},{"name":"Department of Basic Medical Sciences, Faculty of Health Studies, University of Rijeka, Rijeka, Croatia."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2021,9,9]]},"reference":[{"key":"e_1_3_4_2_2","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.ijantimicag.2018.12.001","article-title":"Impact of a multimodal strategy combining a new standard of care and restriction of carbapenems, fluoroquinolones and cephalosporins on antibiotic consumption and resistance of Pseudomonas aeruginosa in a French intensive care unit","volume":"53","author":"Abbara S.","year":"2019","unstructured":"Abbara S., , Pitsch A., , Jochmans S., et al. 2019. Impact of a multimodal strategy combining a new standard of care and restriction of carbapenems, fluoroquinolones and cephalosporins on antibiotic consumption and resistance of Pseudomonas aeruginosa in a French intensive care unit. Int. J. Antimicrob. Agents, 53:416\u2013422.","journal-title":"Int. J. Antimicrob. Agents"},{"key":"e_1_3_4_3_2","unstructured":"ECDC (European Centre for Disease Prevention and Control). 2019. Surveillance of Antimicrobial Resistance in Europe 2018. European Centre for Disease Prevention and Control Stockholm."},{"key":"e_1_3_4_4_2","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1177\/8755122515599407","article-title":"Are fluoroquinolones appropriate for the treatment of extended-spectrum \u03b2-lactamase-producing Gram-negative bacilli? J","volume":"32","author":"Wiener E.S.","year":"2016","unstructured":"Wiener E.S., , Heil E.L, , Hynicka L.M, , and Johnson J.K.. 2016. Are fluoroquinolones appropriate for the treatment of extended-spectrum \u03b2-lactamase-producing Gram-negative bacilli? J. Pharm. Technol. 32:16\u201321.","journal-title":"Pharm. Technol"},{"key":"e_1_3_4_5_2","doi-asserted-by":"crossref","first-page":"19711","DOI":"10.2807\/ese.15.46.19711-en","article-title":"Carbapenem-non-susceptible Enterobacteriaceae in Europe: conclusions from a meeting of national experts","volume":"15","author":"Grundmann H.","year":"2010","unstructured":"Grundmann H., , Livermore D.M, , Giske C.G, et al. 2010. Carbapenem-non-susceptible Enterobacteriaceae in Europe: conclusions from a meeting of national experts. Euro Surveill. 15:19711.","journal-title":"Euro Surveill"},{"key":"e_1_3_4_6_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-0691.2012.03821.x"},{"key":"e_1_3_4_7_2","doi-asserted-by":"crossref","first-page":"128","DOI":"10.3904\/kjim.2012.27.2.128","article-title":"Current epidemiology and growing resistance of gram-negative pathogens","volume":"27","author":"Livermore, D.M","year":"2012","unstructured":"Livermore, D.M. 2012. Current epidemiology and growing resistance of gram-negative pathogens. Korean J. Intern. Med. 27:128\u2013142.","journal-title":"Korean J. Intern. Med"},{"key":"e_1_3_4_8_2","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1080\/1120009X.2018.1434917","article-title":"Impact of cephalosporin restriction on incidence of infections with extended-spectrum beta-lactamase-producing Klebsiella pneumoniae in an endemic setting","volume":"30","author":"Nadrah K.","year":"2018","unstructured":"Nadrah K., , Pirs M., , Kreft S., , Mueller Premru M., , and Beovic B.. 2018. Impact of cephalosporin restriction on incidence of infections with extended-spectrum beta-lactamase-producing Klebsiella pneumoniae in an endemic setting. J. Chemother. 30:150\u2013156.","journal-title":"J. Chemother"},{"key":"e_1_3_4_9_2","doi-asserted-by":"crossref","first-page":"vi50","DOI":"10.1093\/jac\/dky118","article-title":"Metrics for quantifying antibiotic use in the hospital setting: results from a systematic review and consensus procedure","volume":"73","author":"Stani\u0107 Beni\u0107 M","year":"2018","unstructured":"Stani\u0107 Beni\u0107 M, , Milani\u010d R M.A., et al. 2018. Metrics for quantifying antibiotic use in the hospital setting: results from a systematic review and consensus procedure. J. Antimicrob. Chemother. 73:vi50\u2013vi58.","journal-title":"J. Antimicrob. Chemother"},{"key":"e_1_3_4_10_2","unstructured":"Collaborating Centre for Drug Statistics Methodology WHO. 2018. Guidelines for ATC classification and DDD assignment 2019. World Health Organization Norway."},{"key":"e_1_3_4_11_2","first-page":"575","article-title":"Time Series Analysis","author":"Box GEP","year":"1976","unstructured":"Box GEP, J.G. 1976. Time Series Analysis: Forecasting and Control. 2nd ed. Holden Day, San Francisco, CA, p. 575.","journal-title":"Forecasting and Control"},{"key":"e_1_3_4_12_2","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1080\/01621459.1976.10480353","article-title":"Checking the independence of two covariance-stationary time series: a univariate residual cross-correlation approach","volume":"71","author":"Haugh LD","year":"1976","unstructured":"Haugh LD. 1976. Checking the independence of two covariance-stationary time series: a univariate residual cross-correlation approach. J. Am. Stat. Assoc. 71:378\u2013385.","journal-title":"J. Am. Stat. Assoc"},{"key":"e_1_3_4_13_2","doi-asserted-by":"crossref","first-page":"1900656","DOI":"10.2807\/1560-7917.ES.2019.24.46.1900656","article-title":"Decreasing and stabilising trends of antimicrobial consumption and resistance in Escherichia coli and Klebsiella pneumoniae in segmented regression analysis, European Union\/European Economic Area, 2001 to 2018","volume":"24","author":"Pe\u00f1alva G.","year":"2019","unstructured":"Pe\u00f1alva G., , H\u00f6gberg L.D, , Weist K., , Vlahovi\u0107-Pal\u010devski V., , Heuer O., , and Monnet D.L.. 2019. Decreasing and stabilising trends of antimicrobial consumption and resistance in Escherichia coli and Klebsiella pneumoniae in segmented regression analysis, European Union\/European Economic Area, 2001 to 2018. Euro. Surveill. 24:1900656.","journal-title":"Euro. Surveill"},{"key":"e_1_3_4_14_2","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1136\/ejhpharm-2014-000533","article-title":"Assessment of adherence to printed guidelines for antimicrobial drug use in a university hospital","volume":"2","author":"Quadranti R.N.","year":"2015","unstructured":"Quadranti R.N., , Popovi\u0107 B., , I. \u0160krobonja, Sko\u010dibu\u0161i\u0107 N., , Vlahovi\u0107-Pal\u010devski V.. 2015. Assessment of adherence to printed guidelines for antimicrobial drug use in a university hospital. Eur. J. Hosp. Pharm. 2:113\u2013117.","journal-title":"Eur. J. Hosp. Pharm"},{"key":"e_1_3_4_15_2","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1001\/jamainternmed.2015.1878","article-title":"Effectiveness of an antimicrobial stewardship approach for urinary catheter-associated asymptomatic bacteriuria","volume":"175","author":"Trautner B.W.","year":"2015","unstructured":"Trautner B.W., , Grigoryan L., , Petersen N.J, et al. 2015. Effectiveness of an antimicrobial stewardship approach for urinary catheter-associated asymptomatic bacteriuria. JAMA Intern. Med. 175:1120\u20131127.","journal-title":"JAMA Intern. Med"},{"key":"e_1_3_4_16_2","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1093\/jac\/46.3.501","article-title":"Appropriate use of restricted antimicrobial agents in hospitals: the importance of empirical therapy and assisted re-evaluation","volume":"46","author":"Thuong M.","year":"2000","unstructured":"Thuong M., , Shortgen F., , Zazempa V., , Girou E., , Soussy C.J, , and Brun-Buisson C.. 2000. Appropriate use of restricted antimicrobial agents in hospitals: the importance of empirical therapy and assisted re-evaluation. J. Antimicrob. Chemother. 46:501\u2013508.","journal-title":"J. Antimicrob. Chemother"},{"key":"e_1_3_4_17_2","doi-asserted-by":"crossref","first-page":"339","DOI":"10.7150\/ijms.8.339","article-title":"The impact of a nationwide antibiotic restriction program on antibiotic usage and resistance against nosocomial pathogens in Turkey","volume":"8","author":"Altunsoy A.","year":"2011","unstructured":"Altunsoy A., , Aypak C., , Azap A., , \u00d6. Erg\u00f6n\u00fcl, and Bal\u0131k I.. 2011. The impact of a nationwide antibiotic restriction program on antibiotic usage and resistance against nosocomial pathogens in Turkey. Int. J. Med. Sci. 8:339\u2013344.","journal-title":"Int. J. Med. Sci"},{"key":"e_1_3_4_18_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/38.5.895"},{"key":"e_1_3_4_19_2","doi-asserted-by":"publisher","DOI":"10.1136\/emermed-2014-204067"},{"key":"e_1_3_4_20_2","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s13756-018-0302-8","article-title":"Higher third-generation cephalosporin prescription proportion is associated with lower probability of reducing carbapenem use: a nationwide retrospective study","volume":"7","author":"Muller A.","year":"2018","unstructured":"Muller A., , Bertrand X., , Rogues A.-M, et al. 2018. Higher third-generation cephalosporin prescription proportion is associated with lower probability of reducing carbapenem use: a nationwide retrospective study. Antimicrob. Resist. Infect. Control, 7:11.","journal-title":"Antimicrob. Resist. Infect. Control"},{"key":"e_1_3_4_21_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.280.14.1233"},{"key":"e_1_3_4_22_2","doi-asserted-by":"crossref","first-page":"149","DOI":"10.2147\/IDR.S22491","article-title":"Impact of restriction of cefepime use on the antimicrobial susceptibility of Gram-negative bacilli related to healthcare-associated infections in an orthopedic hospital","volume":"4","author":"Oliveira P.R.","year":"2011","unstructured":"Oliveira P.R., , Paula A.P, , Dal-Paz K., et al. 2011. Impact of restriction of cefepime use on the antimicrobial susceptibility of Gram-negative bacilli related to healthcare-associated infections in an orthopedic hospital. Infect. Drug Resist. 4:149\u2013154.","journal-title":"Infect. Drug Resist"},{"key":"e_1_3_4_23_2","doi-asserted-by":"crossref","first-page":"e86457","DOI":"10.1371\/journal.pone.0086457","article-title":"A multidisciplinary intervention to reduce infections of ESBL- and AmpC-producing, gram-negative bacteria at a University Hospital","volume":"9","author":"Knudsen J.D.","year":"2014","unstructured":"Knudsen J.D., , and Andersen S.E.. 2014. A multidisciplinary intervention to reduce infections of ESBL- and AmpC-producing, gram-negative bacteria at a University Hospital. PLoS One, 9:e86457.","journal-title":"PLoS One"},{"key":"e_1_3_4_24_2","first-page":"DC08","article-title":"Relationship between antimicrobial consumption and the incidence of antimicrobial resistance in Escherichia coli and Klebsiella pneumoniae Isolates","volume":"9","author":"Joseph N.M.","year":"2015","unstructured":"Joseph N.M., , Bhanupriya B., , Shewade D.G, , and Harish B.N.. 2015. Relationship between antimicrobial consumption and the incidence of antimicrobial resistance in Escherichia coli and Klebsiella pneumoniae Isolates. J. Clin. Diagn. Res. 9:DC08-12.","journal-title":"J. Clin. Diagn. Res"},{"key":"e_1_3_4_25_2","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.ijantimicag.2015.03.005","article-title":"Forecasting carbapenem resistance from antimicrobial consumption surveillance: lessons learnt from an OXA-48-producing Klebsiella pneumoniae outbreak in a West London renal unit","volume":"46","author":"Gharbi M.","year":"2015","unstructured":"Gharbi M., , Moore L.S.P, , Gilchrist M., et al. 2015. Forecasting carbapenem resistance from antimicrobial consumption surveillance: lessons learnt from an OXA-48-producing Klebsiella pneumoniae outbreak in a West London renal unit. Int. J. Antimicrob. Agents, 46:150\u2013156.","journal-title":"Int. J. Antimicrob. Agents"},{"key":"e_1_3_4_26_2","doi-asserted-by":"crossref","first-page":"219","DOI":"10.12659\/MSM.892516","article-title":"Risk factors of carbapenem-resistant Klebsiella pneumoniae infection: a serious threat in ICUs","volume":"21","author":"Candevir Ulu A.","year":"2015","unstructured":"Candevir Ulu A., , Kurtaran B., , Inal A.S, et al. 2015. Risk factors of carbapenem-resistant Klebsiella pneumoniae infection: a serious threat in ICUs. Med. Sci. Monit. 21:219\u2013224.","journal-title":"Med. Sci. Monit"},{"key":"e_1_3_4_27_2","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1128\/AAC.01131-09","article-title":"Treatment with fluoroquinolones or with beta-lactam-beta-lactamase inhibitor combinations is a risk factor for isolation of extended-spectrum-beta-lactamase-producing Klebsiella species in hospitalized patients","volume":"54","author":"Wener K.M.","year":"2010","unstructured":"Wener K.M., , Schechner V., , Gold H.S, , Wright S.B, , and Carmeli Y.. 2010. Treatment with fluoroquinolones or with beta-lactam-beta-lactamase inhibitor combinations is a risk factor for isolation of extended-spectrum-beta-lactamase-producing Klebsiella species in hospitalized patients. Antimicrob. Agents Chemother. 54:2010\u20132016.","journal-title":"Antimicrob. Agents Chemother"},{"key":"e_1_3_4_28_2","doi-asserted-by":"crossref","first-page":"271","DOI":"10.3389\/fmicb.2020.00271","article-title":"Global evolution of pathogenic bacteria with extensive use of fluoroquinolone agents","volume":"11","author":"Fuzi M.","year":"2020","unstructured":"Fuzi M., , Rodriguez Bano J., , and Toth A.. 2020. Global evolution of pathogenic bacteria with extensive use of fluoroquinolone agents. Front. Microbiol. 11:271.","journal-title":"Front. Microbiol"},{"key":"e_1_3_4_29_2","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1017\/ice.2019.155","article-title":"Attributable mortality due to fluoroquinolone and extended-spectrum cephalosporin resistance in hospital-onset Escherichia coli and Klebsiella spp bacteremia: A matched cohort study in 129 Veterans Health Administration medical centers","volume":"40","author":"Suzuki H.","year":"2019","unstructured":"Suzuki H., , Perencevich E.N, , Livorsi D.J, et al. 2019. Attributable mortality due to fluoroquinolone and extended-spectrum cephalosporin resistance in hospital-onset Escherichia coli and Klebsiella spp bacteremia: A matched cohort study in 129 Veterans Health Administration medical centers. Infect. Control Hosp. Epidemiol. 40:928\u2013931.","journal-title":"Infect. Control Hosp. Epidemiol"},{"key":"e_1_3_4_30_2","first-page":"S495","article-title":"Telephone versus clinic follow-up in management of patients with inflammatory bowel disease","volume":"10","author":"Chauhan U.","year":"2016","unstructured":"Chauhan U., , Armstrong D., , Halder S.L, et al. 2016. Telephone versus clinic follow-up in management of patients with inflammatory bowel disease. Can. J. Gastroenterol. Hepatol. Conf. 10:S495.","journal-title":"Can. J. Gastroenterol. Hepatol. Conf"},{"key":"e_1_3_4_31_2","doi-asserted-by":"publisher","DOI":"10.1089\/mdr.2012.0067"},{"key":"e_1_3_4_32_2","first-page":"523","article-title":"Evaluation of the efficiency of hospital antibiotic policy applied Dr Jan Biziel University Hospital No 2 in Bydgoszcz in 2009\u20132013","volume":"69","author":"Kuziemski A.","year":"2015","unstructured":"Kuziemski A., , Frankowska K., , Gonia E., , Czerniak B., , Bakhurynska O., , and Sobocinski Z.. 2015. Evaluation of the efficiency of hospital antibiotic policy applied Dr Jan Biziel University Hospital No 2 in Bydgoszcz in 2009\u20132013. Przegl. Epidemiol. 69:523\u2013528, 633\u2013636.","journal-title":"Przegl. Epidemiol"},{"key":"e_1_3_4_33_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.2011.04161.x"},{"key":"e_1_3_4_34_2","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/s13756-019-0484-8","article-title":"Influence of antibiotic pressure on multi-drug resistant Klebsiella pneumoniae colonisation in critically ill patients","volume":"8","author":"Ruiz J.","year":"2019","unstructured":"Ruiz J., , Gordon M., , Villarreal E., et al. 2019. Influence of antibiotic pressure on multi-drug resistant Klebsiella pneumoniae colonisation in critically ill patients. Antimicrob. Resist. Infect. Control, 8:38.","journal-title":"Antimicrob. Resist. Infect. Control"},{"key":"e_1_3_4_35_2","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1592\/phco.22.1.81.33508","article-title":"The effect of an antimicrobial formulary change on hospital resistance patterns","volume":"22","author":"Empey K.M.","year":"2002","unstructured":"Empey K.M., , Rapp R.P, , and Evans M.E.. 2002. The effect of an antimicrobial formulary change on hospital resistance patterns. Pharmacotherapy, 22:81\u201387.","journal-title":"Pharmacotherapy"},{"key":"e_1_3_4_36_2","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1093\/jac\/dkm225","article-title":"Control of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in a children's hospital by changing antimicrobial agent usage policy","volume":"60","author":"Lee J.","year":"2007","unstructured":"Lee J., , Pai H., , Kim Y.K, et al. 2007. Control of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in a children's hospital by changing antimicrobial agent usage policy. J. Antimicrob. Chemother. 60:629\u2013637.","journal-title":"J. Antimicrob. Chemother"},{"key":"e_1_3_4_37_2","doi-asserted-by":"crossref","first-page":"438","DOI":"10.3109\/00365548.2012.760845","article-title":"Impact of a hospital-wide antibiotic restriction policy program on the resistance rates of nosocomial Gram-negative bacteria","volume":"45","author":"Antoniadou A.","year":"2013","unstructured":"Antoniadou A., , Kanellakopoulou K., , Kanellopoulou M., et al. 2013. Impact of a hospital-wide antibiotic restriction policy program on the resistance rates of nosocomial Gram-negative bacteria. Scand. J. Infect. Dis. 45:438\u2013445.","journal-title":"Scand. J. Infect. Dis"},{"key":"e_1_3_4_38_2","doi-asserted-by":"crossref","first-page":"e398","DOI":"10.1016\/S2542-5196(18)30186-4","article-title":"Anthropological and socioeconomic factors contributing to global antimicrobial resistance: a univariate and multivariable analysis","volume":"2","author":"Collignon P.","year":"2018","unstructured":"Collignon P., , Beggs J.J, , Walsh T.R, , Gandra S., , and Laxminarayan R.. 2018. Anthropological and socioeconomic factors contributing to global antimicrobial resistance: a univariate and multivariable analysis. Lancet. Planet. Heal. 2:e398\u2013e405.","journal-title":"Lancet. Planet. Heal"},{"key":"e_1_3_4_39_2","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1136\/bmjqs-2012-001791","article-title":"A managed multidisciplinary programme on multi-resistant Klebsiella pneumoniae in a Danish university hospital","volume":"22","author":"Andersen S.E.","year":"2013","unstructured":"Andersen S.E., , and Knudsen J.D.. 2013. A managed multidisciplinary programme on multi-resistant Klebsiella pneumoniae in a Danish university hospital. BMJ Qual. Saf. 22:907\u2013915.","journal-title":"BMJ Qual. Saf"}],"updated-by":[{"DOI":"10.1089\/mdr.2020.0301.retract","type":"retraction","label":"Retraction","source":"retraction-watch","updated":{"date-parts":[[2021,12,17]],"date-time":"2021-12-17T00:00:00Z","timestamp":1639699200000},"record-id":"34861"}],"container-title":["Microbial Drug Resistance"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1089\/mdr.2020.0301","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/mdr.2020.0301","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/mdr.2020.0301","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T20:38:22Z","timestamp":1777667902000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.1089\/mdr.2020.0301"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":38,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2021,9]]}},"alternative-id":["10.1089\/mdr.2020.0301"],"URL":"https:\/\/doi.org\/10.1089\/mdr.2020.0301","relation":{},"ISSN":["1076-6294","1931-8448"],"issn-type":[{"value":"1076-6294","type":"print"},{"value":"1931-8448","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9]]}}}